CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6932 result(s)

Apomorphine (Movapo)

Last Updated: April 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: apomorphine hydrochloride
Indications: Parkinson's disease

  • Brand Name: Movapo
  • Manufacturer: Paladin Labs Inc.
  • Project Number: SR0527-000
  • Project Status: Complete
  • Submission Type: New

Evolocumab (Repatha)

Last Updated: June 7, 2017
Result type: Reports
Product Line: Common Drug Review
Generic Name: Evolocumab
Indications: Primary hyperlipidemia and mixed dyslipidemia

  • Brand Name: Repatha
  • Manufacturer: Amgen Canada Inc.
  • Project Number: SR0515-000
  • Project Status: Complete
  • Submission Type: Resubmission

Emerging Non-Opioid Drugs for the Treatment of Pain

Last Updated: February 16, 2018
Result type: Reports
Product Line: Environmental Scans

Opioids are used extensively in the treatment of pain. Even with the growing awareness about the risks associated with opioids and the recognition of the current opioid crisis, the number of prescriptions for opioids is still rising in Canada. Safe and effective pharmacological alternatives to opioids could have a significant impact on the op...

  • Project Number: ES0322-000